This notion is supported by a study by Hassan et al, which demonstrated that MSLN concentrations were significantly elevated in the serum of 67% of ovarian cancer patients, thereby further substantiating the distinctive expression profile of MSLN expression in ovarian cancer.38 The gene discussed is MSLN; the disease is ovarian carcinoma.